Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Meso Scale Discovery UPLEX HUM APRIL/TNFSF1ASY384
SDP

Catalog No. 5000080985
Encompass

The Meso Scale Discovery U-PLEX Human APRIL (TNFSF13) Assay is a 384-well electrochemiluminescent immunoassay designed to measure APRIL levels in human serum plasma and cell culture supernatants This assay utilizes MSD s proprietary SULFO-TAG labels and multi-array plate technology to provide sensitive and reproducible quantitation of APRIL with a broad dynamic range The kit includes a 384-well plate coated with an APRIL capture antibody detection antibody conjugated to an electrochemiluminescent label calibrators and buffers for sample dilution The assay has a lower limit of detection of 0 04 ng/mL and an upper limit of 10 000 pg/mL

Catalog No. 50-000-80985 Supplier Meso Scale Discovery Supplier No. K251AGUK2
May include imposed supplier surcharges.
Add to Cart
Add to Cart
Request a Quote

missing translation for 'validMainframeMsg'

The Meso Scale Discovery U-PLEX Human APRIL (TNFSF13) Assay is a 384-well electrochemiluminescent immunoassay designed to measure APRIL levels in human serum plasma and cell culture supernatants This assay utilizes MSD s proprietary SULFO-TAG labels and multi-array plate technology to provide sensitive and reproducible quantitation of APRIL with a broad dynamic range The kit includes a 384-well plate coated with an APRIL capture antibody detection antibody conjugated to an electrochemiluminescent label calibrators and buffers for sample dilution The assay has a lower limit of detection of 0 04 ng/mL and an upper limit of 10 000 pg/mL

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.